Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

ExpreS2ion Biotech Holding AB

EXPRS2.ST ✓ COMPLIANT ☆ Track — members

Nasdaq Stockholm · Healthcare · Pharmaceuticals ·

Sweden Micro Cap Analyst: N/A

Last Close

$0.14

▲ +4.42%

Market Cap $3.24M · Vol 34.42K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.24M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

38.57

Momentum

Beta

2.96

vs Market

52W High

$0.88

84.86% below

52W Low

$0.11

17.40% above

Volume

34.42K

Avg 173.01K

P/B

1.57

Price-to-book

ROE

N/A

Return on equity

Free Float

99.89%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, ExpreS2ion Biotech Holding AB (EXPRS2.ST) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does EXPRS2.ST pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-7.14%

-21.45%

-76.09%

YTD

-77.11%

-84.14%

-95.83%

-99.75%

Financials & Valuation

TTM · Annual

Total Revenue	$1.33M
Net Income	$-4,140,124.00
Revenue Growth (YoY)	+237.73%
Gross Margin	59.15%
Operating Margin	-362.66%
Net Profit Margin	-311.99%
ROE	N/A
ROA · ROIC	-51.97% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	3.71
P/B	1.57
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	23.75M

Technical Indicators

50-Day SMA	$0.15
200-Day SMA	$0.34
RSI (14)	38.57
Beta	2.96
52-Week High	$0.88
52-Week Low	$0.11

Volume Today	34.42K
Avg Daily Volume (30D)	173.01K
Relative Volume	0.20x
Volatility (10D)	71.41
Volatility (30D)	66.74
Free Float	99.89%

Analyst Consensus

N/A

Current Price $0.14

Mean Target $0.53

52W Low$0.11 52W High$0.88

Current

Target

$0.11 $0.88

Current Analyst target

+289.13% upside potential · 0 analysts

Identifiers

ExchangeNasdaq Stockholm

FIGIBBG00D3JNGT4

ISINSE0023261292

CountrySweden

Sub-IndustryBiopharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -1.67% CSL.AX CSL Ltd -0.90% 207940.KS Samsung Biologics Co Ltd -6.78% UCB.BR Ucb SA -2.43% BIIB Biogen Inc -1.35%

Company Profile

ExpreS2ion Biotech Holding AB is a Sweden-based biopharmaceutical company. The Company specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The Company's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. It also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.